Hello. I am Jennifer.
Chat with me if you have any questions.
Allergan, Inc. (NYSE:AGN) announced the U.S. Food and Drug Administration’s (FDA) approval of JUVEDERM(R) XC, a new formulation of the currently FDA-approved JUVEDERM(R) dermal filler and the latest advancement1 in hyaluronic acid (HA) dermal fillers.
In this study, we examined Radiesse (calcium hydroxylapatite; CaHA), Juvederm 24 (hyaluronic acid; HA-1A), Juvederm 24HV (HA-1B), and Perlane (HA-2) for patient satisfaction, likelihood to return, immediate efficacy, and duration of … (Source: Dermatologic Surgery)
Only Hyaluronic Acid Dermal Fillers Approved to Last up to 1 Year IRVINE, Calif.–(HSMN NewsFeed)–Allergan, Inc. (NYSE:AGN ), the maker of BOTOX? Cosmetic (Botulinum Toxin Type A), today announced approval by the U.S.
Allergan-supported scientific posters on BOTOX(R) Cosmetic (botulinum toxin type A), BOTOX(R) (botulinum toxin type A) for hyperhidrosis and JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS, the “next-generation” hyaluronic acid dermal fillers, will be presented at this year’s winter meeting of the American Academy of Dermatology (AAD). …
The FDA has approved a series of hyaluronic acid gel implants (Juvederm 24HV, 30, and 30HV) and a gastrointestinal monitoring device (SmartPill pH.p).Medscape Medical NewsYael Waknine (Source: Medscape Medical News Headlines)
Copryright 2012 - Epione Medical Corporation | About us | Treatments | Contact us | Online Store
